Skip to main content
. 2021 May 19;41(1):74–82. doi: 10.14366/usg.21011

Table 2.

Summarized diagnoses for CEUS LI-RADS category M observations

Study Total No. of LR-M observations No. of HCCs (%) No. of non-HCC malignancies (%) Non-HCC malignancy diagnoses (n) No. of benign lesions (%) Benign diagnoses (n)
Schellhaas et al. [11] 6 3 (50) 3 (50) iCCA (3) 0 -
Terzi et al. [12] 82 39 (48) 43 (52) iCCA (31), cHCC-CCA (8), metastasis (2), lymphoma (2) 0 -
Ling et al. [13] 9 7 (78) 1 (11) iCCA (1) 1 (11) Reactive lymphoid hyperplasia (1)
Chen et al. [14] 138 38 (28) 100 (72) iCCA (100) 0 -
Li et al. [15] 288 172 (60) 95 (33) Not specified 21 (7) Not specified
Lyshchik et al. [21] 11 5 (45) 6 (55) iCCA (2), metastasis (4) 0 -
Zheng et al. [16] 354 224 (63) 127 (36) iCCA (54), cHCC-CCA (20), metastasis (50), others (3) 3 (1) Biliary adenoma (1), inflammatory pseudotumor (1), liver abscess (1)
Huang et al. [17] 20 15 (75) 2 (10) iCCA (2) 3 (15) Biliary adenoma (1), hemangioma (1), reactive lymphoid hyperplasia (1)
Tan et al. [18] 1 1 (100) 0 - 0 -
Makoyeva et al. [19] 26 9 (34) 16 (62) iCCA (8), metastasis (6), lymphoma (1), perivascular epithelioid cell neoplasm (1) 1 (4) Regenerative nodule (1)
Zhou et al. [20] 43 25 (58) 17 (40) Not specified 1 (2) Not specified
Ding et al. [22] 68 41 (60) 22 (32) Not specified 5 (8) Not specified

CEUS, contrast-enhanced ultrasonography; LI-RADS, Liver Imaging Reporting and Data System; LR-M, Liver Imaging Reporting and Data System category M; HCC, hepatocellular carcinoma; iCCA, intrahepatic cholangiocarcionoma; cHCC-CCA, combined hepatocellular cholangiocarcinoma.